Dr Agarwal's Health Care Ltd IPO

Dr Agarwal's Health Care Ltd IPO

Healthcare

mainboard

Bidding period

29 Jan 2025 - 31 Jan 2025

Bid price

₹402.00 - ₹402.00

Listing on

BSE, NSE

Listing date

04 Feb 2025

Lot size

35 shares

Issue size

₹3,027.26 crore


Minimum investment

₹14,070.00 / 1 lot

Maximum investment

₹1,96,980.00 / 14 lot

Bidding closed on 31 Jan 2025

EXPLORE IPOs
EXPLORE IPOs

Dr Agarwal's Health Care Ltd IPO dates

IPO opening date

29 Jan 2025

IPO end date

31 Jan 2025

Allotment date

01 Feb 2025

Initiation of refunds

03 Feb 2025

Credit of shares to demat

03 Feb 2025

IPO listing date

04 Feb 2025

Dr Agarwal's Health Care Ltd IPO financials

Particulars

For the period ending in March 2024 (in ₹ million)

Total assets ₹2,752.82
Total liabilities ₹2,752.82
Total expenditure ₹1,235.88
Total revenue ₹1,376.45
Profit after tax ₹83.06
EBITDA ₹406.55
Adjusted EBITDA ₹0.00

Dr Agarwal's Health Care Ltd shareholder pattern

Pre-issue Post-issue
Promoter group 37.72 32.45
Public group 62.28 67.55

Dr Agarwal's Health Care Ltd strengths and risks

Information currently unavailable

  • Largest eyecare services provider in India with a trusted brand.

  • End-to-end, comprehensive eyecare services offering.

  • Scalable, asset-light, hub-and-spoke operating model.

  • Proven clinical excellence driven by a strong clinical board and history of surgical innovations.

  • Doctor-promoters leading a team of qualified medical professionals and supported by an experienced management.

  • Proven track record of delivering organic growth, integrating and scaling acquisitions and improving operating profitability.

  • The company engage doctors through retainership arrangements and there is no assurance that its doctors will not prematurely terminate their arrangements with it. If the company is not able to attract and retain its doctors and other medical professionals, the company business, financial condition, results of operations and cash flows may be adversely affected.

  • The company business depends on the strength of the company brand equity and reputation. Failures to maintain and enhance its brand equity and reputation, including due to negative publicity, may adversely affect its business, reputation, financial condition, results of operations and prospects.

  • The company operates in a regulated industry, and its failures to comply with applicable safety, health, environmental, labor and other regulations, or to obtain or renew approvals, may adversely affect its business, reputation, financial condition, results of operations and cash flows.

  • A significant majority of its Facilities are located in the states of Tamil Nadu (in particular, Chennai), Maharashtra and Karnataka in India and any adverse developments in relation to these Facilities could adversely affect its business, financial condition, results of operations and cash flows.

  • The company is exposed to legal claims and regulatory actions arising from the provision of healthcare services and may be subject to liabilities arising from claims of malpractice and medical negligence which could adversely affect its business, financial condition, results of operations, cash flows, reputation and prospects.

  • Its international operations expose it to management, legal, tax, political and economic risks, and its failure to address such risks could adversely affect the company business, results of operations, financial condition and cash flows.

  • Its hub-and-spoke model may not be successful and the company may not be able to expand into new geographic regions, which could adversely affect its business, financial condition and results of operations.

  • The company has pursued and will likely continue to pursue strategic acquisitions for inorganic growth. Its inability to successfully identify, acquire and integrate suitable opportunities on commercially reasonable terms in the future could adversely affect its business, financial condition, cash flows and results of operations.

  • Its historical performance is not indicative of the company future growth or financial results and if its fail to manage the company growth or implement its growth strategies, the company business, financial condition and results of operations may be adversely affected.

  • The company is exposed to credit risks in respect of payments from third parties including under central and state government schemes, government corporations, insurance companies and third party administrators. If the company does not receive payments on a timely basis, its business, financial condition, results of operations, cash flows and prospects may be adversely affected.

How to check the allotment status of the Dr Agarwal's Health Care Ltd IPO?

To check the IPO allotment status, follow these steps:

 

  1. Visit the official website of the IPO’s registrar.
  2. Go to the IPO allotment status page.
  3. Select the ‘Dr Agarwal's Health Care Ltd’ from the list of available IPOs.
  4. Enter your PAN, Demat ID, or application number.
  5. Click on ‘Submit’ or ‘Check Status’ to view your allotment details.

Alternatively, you can also check the allotment status on stock exchange websites such as the NSE or BSE.

To check the IPO allotment status, follow these steps:

 

  1. Visit the official website of the IPO’s registrar.
  2. Go to the IPO allotment status page.
  3. Select the ‘Dr Agarwal's Health Care Ltd’ from the list of available IPOs.
  4. Enter your PAN, Demat ID, or application number.
  5. Click on ‘Submit’ or ‘Check Status’ to view your allotment details.

Alternatively, you can also check the allotment status on stock exchange websites such as the NSE or BSE.

Read more Read less

Dr Agarwal's Health Care Ltd IPO registrar

KFin Techologies Ltd

Phone number +91 40 6716 2222
E-mail ID einward.ris@kfintech.com
Website www.kfintech.com

Dr Agarwal's Health Care Ltd IPO reservation

QIB shares offered

1,45,19,199 (19.28%)

NII (HNI) shares offered

1,08,89,400 (14.46%)

Retail shares offered

2,54,08,600 (33.74%)

Anchor investor shares offered

2,17,78,800 (28.92%)

Total shares offered

7,53,04,968

Total shares with anchor investor

7,53,04,968

Dr Agarwal's Health Care Ltd IPO lead manager

  • Kotak Mahindra Capital Company Ltd
  • Morgan Stanley India Company Pvt Ltd
  • Jefferies India Pvt Ltd
  • Motilal Oswal Investment Advisors Ltd

Explore other IPOs

Aditya Infotech Limited logo
Aditya Infotech Limited logo

Aditya Infotech Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advance Agrolife Limited logo
Advance Agrolife Limited logo

Advance Agrolife Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advanced SysTek Limited logo
Advanced SysTek Limited logo

Advanced SysTek Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Aegis Vopak Terminals Limited logo
Aegis Vopak Terminals Limited logo

Aegis Vopak Terminals Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Agilus Diagnostics Limited logo
Agilus Diagnostics Limited logo

Agilus Diagnostics Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Airox Technologies Limited logo
Airox Technologies Limited logo

Airox Technologies Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Ajay Poly Limited logo
Ajay Poly Limited logo

Ajay Poly Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
All Time Plastics Limited logo
All Time Plastics Limited logo

All Time Plastics Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Allchem Lifescience Limited logo
Allchem Lifescience Limited logo

Allchem Lifescience Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Amanta Healthcare Limited logo
Amanta Healthcare Limited logo

Amanta Healthcare Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Anand Rathi Share AND Stock Brokers Limited logo
Anand Rathi Share AND Stock Brokers Limited logo

Anand Rathi Share AND Stock Brokers Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Anlon Healthcare Limited logo
Anlon Healthcare Limited logo

Anlon Healthcare Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Anthem Biosciences Limited logo
Anthem Biosciences Limited logo

Anthem Biosciences Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
AOne Steels India Limited logo
AOne Steels India Limited logo

AOne Steels India Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Ardee Engineering Limited logo
Ardee Engineering Limited logo

Ardee Engineering Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Armee Infotech Limited logo
Armee Infotech Limited logo

Armee Infotech Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Asirvad Microfinance Limited logo
Asirvad Microfinance Limited logo

Asirvad Microfinance Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Atlanta Electricals Limited logo
Atlanta Electricals Limited logo

Atlanta Electricals Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Avanse Financial Services Limited logo
Avanse Financial Services Limited logo

Avanse Financial Services Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced

How to apply for an IPO with Bajaj Broking?

adafafds
 
 
  • Log in to the Bajaj Broking trading platform and select ‘IPO’ from the menu.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen IPO.
  • Enter the quantity and your UPI ID.
  • Submit your application—and you're done!

Frequently asked questions

What is the listing date for the Dr Agarwal's Health Care Ltd IPO?

The listing date for the Dr Agarwal's Health Care Ltd IPO is 04 Feb 2025.

What is the issue size of Dr Agarwal's Health Care Ltd IPO?

The issue size of the Dr Agarwal's Health Care Ltd IPO is ₹3,027.26 cr.

What is the minimum lot size needed for Dr Agarwal's Health Care Ltd IPO?

The minimum lot size for Dr Agarwal's Health Care Ltd IPO is 35

When does the Dr Agarwal's Health Care Ltd open and close?

Dr Agarwal's Health Care Ltd IPO is open from 29 Jan 2025 to 31 Jan 2025.

How can I apply for the Dr Agarwal's Health Care Ltd IPO?

To apply for the Dr Agarwal's Health Care Ltd, follow the steps given below:

  • Log in to your Bajaj Broking trading account and navigate to the current IPOs section.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen PO.
  • Enter the quantity and your UPI ID. You will receive a mandate notification to block funds in your UPI app.
SHOW MORE SHOW LESS

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines.
Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.

Powered by Bajaj Financial Securities Limited (Bajaj Broking)